Avita Medical | 1811094D - 流动资产



金融业
股票价格
AUD 4.68
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 593.86M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


流动资产 更改 日
Accuray USD 292.39M 11.22M 2025-12
Celltrion KRW 493.66B 12.09B 2026-06
Clinuvel Pharmaceuticals AUD 261.38M 1.59M 2025-12
Cochlear AUD 1.37B 43.9M 2025-12
CSL USD 11.85B 1000K 2025-12
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 897.54M 222.37M 2026-06
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Kangmei Pharma CNY 6.66B 143.43M 2026-06
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Mayne Pharma AUD 460.59M 14.71M 2024-06
Medical Developments International AUD 33.75M 1.79M 2025-12
Nanosonics AUD 234.13M 8.81M 2025-12
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organigram Holdings CAD 250.09M 6.46M 2026-03
Ovoca Bio EUR 2.07M 510K 2025-12
Pacific Edge NZD 13.77M 15.81M 2026-06
Pharma Mar EUR 280.95M 7.5M 2026-06
Polynovo AUD 69.23M 7.87M 2025-12
PYC Therapeutics AUD 153.74M 23.79M 2025-12
Qiagen NV USD 1.66B 116.37M 2026-06
Ramsay Health Care AUD 3.56B 480.3M 2025-12
ResMed USD 4.06B 245.26M 2026-03
Sartorius EUR 1.65B 8.4M 2026-09
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Telix Pharmaceuticals AUD 488.02M 157.74M 2026-06
Tilray USD 729.32M 28.18M 2025-09
Zealand Pharma A/S 15.02B 652.12M 2026-03
Zz Pientze Pharmaceu CNY 11.16B 270.46M 2026-06